Source Antibiotic Fosfomycin Calcium for Medicine, Feed, and Pharma

Strategic Sourcing Guide for Antibiotic Fosfomycin Calcium

Understanding Product Specifications and Chemical Identity

When initiating a procurement strategy for antibiotic fosfomycin calcium, the first critical step is establishing a precise understanding of the product's technical identity. The core chemical entity is identified by the CAS number 26016-98-8, which serves as the definitive fingerprint for verification against supplier documentation. The molecular formula, recorded as C3h5cao4p in available product data, represents the specific stoichiometric composition of the calcium salt form of fosfomycin. Buyers must recognize that this compound is fundamentally a solid-state material, typically presented in a white powder form. This physical state is consistent across various grades, including medicine grade, food grade, and pharma grade, though the intended application dictates the purity requirements.

The physical appearance is a primary quality indicator. The product is consistently described as a white powder, which aligns with standard expectations for high-purity antibiotic intermediates. However, the state of the material is not merely aesthetic; it impacts handling, storage, and dissolution rates in downstream manufacturing processes. The material is noted as non-volatile, a crucial safety and handling characteristic that simplifies logistics compared to volatile organic compounds. This non-volatile nature ensures that the substance remains stable during transport and storage without the risk of evaporation or concentration changes due to atmospheric conditions.

Purity levels are a significant variable in the market. Observed specifications indicate purity thresholds such as greater than 98% and greater than 99%. These figures are not universal guarantees for every listing but represent the range of quality tiers available. A procurement specialist must verify the specific assay value for their intended use, as some listings cite an assay of 300u/Mg, while others focus on weight-based purity percentages. The distinction between these metrics is vital for regulatory compliance and formulation accuracy. Furthermore, the product model varies significantly depending on the classification, with designations ranging from "HB-Fosfomycin Calcium" to generic "EP" or "food additives" models. This variation underscores the necessity of matching the specific product model to the regulatory framework of the destination market.

Compliance, Certification, and Regulatory Standards

Navigating the regulatory landscape for fosfomycin calcium requires a rigorous verification of certifications and adherence to international standards. The supply chain for this antibiotic is heavily regulated, with certifications serving as the primary proxy for quality assurance. Available data indicates a diverse portfolio of certifications held by suppliers, including RoHS, QS, ISO, CE, CCC, BP, USP, HSE, and GMP. The presence of GMP (Good Manufacturing Practice) is particularly critical for pharma-grade materials, ensuring that the manufacturing environment meets strict hygiene and process control standards. Similarly, the USP (United States Pharmacopeia) and BP (British Pharmacopoeia) standards are essential for products intended for Western markets, providing a benchmark for chemical identity and purity.

The standardization of the product is equally important. Listings reference specific standards such as EP (European Pharmacopoeia), which often dictates the strictest purity and impurity limits for pharmaceutical ingredients. In addition to pharmacopoeial standards, some products are categorized under "Medicine Grade" or "Pharma Grade," while others are listed as "Food Grade." This classification directly influences the permissible applications and the required documentation for customs clearance. For instance, a product labeled as "Food Grade" may not meet the stringent impurity limits required for human pharmaceuticals, even if the chemical identity is identical.

Buyers must also verify the origin of the product, as geographical location can impact regulatory acceptance. The primary origin noted in the market data is China, with specific mentions of Shaanxi province. While China is a major hub for pharmaceutical intermediates, buyers should ensure that the specific facility holds the necessary local and international certifications to export to their target region. The presence of ISO certification is a baseline requirement, but the specific type of ISO (e.g., ISO 9001 for quality management) should be confirmed. Additionally, the "HSE" (Health, Safety, and Environment) certification indicates a supplier's commitment to safe handling and environmental compliance, which is increasingly important for global supply chain sustainability goals.

Cost Drivers and Pricing Dynamics

The pricing structure for fosfomycin calcium is influenced by a complex interplay of factors, including grade, purity, packaging, and order volume. The observed market price range spans from $0.01 to $300 per unit, a wide variance that reflects the difference between bulk raw material pricing and smaller, high-purity pharmaceutical lots. This range is not indicative of a single product but rather the spectrum of available offerings, from industrial-grade intermediates to certified pharmaceutical excipients.

Volume is a primary cost driver. The Minimum Order Quantity (MOQ) varies drastically, ranging from 1 kg to 1,000,000 units. Small-scale buyers may find suppliers with an MOQ of 1 kg, which is suitable for R&D or clinical trials, while large-scale manufacturers will negotiate based on bulk orders that can reach millions of units. The pricing per unit typically decreases as the order volume increases, reflecting economies of scale in production and logistics. However, buyers must be cautious of prices that seem abnormally low, as they may indicate lower purity grades or non-compliant manufacturing processes.

Packaging also plays a significant role in the final cost. Standard packaging includes 25 kg bags, fiber drums, and 20 kg drums. Specialized packaging options, such as aluminum foil bags or carton boxes, may incur additional costs but are necessary for maintaining product integrity during long-distance shipping. The choice of packaging can affect the shelf life and stability of the product, which in turn influences the overall cost of ownership. For example, products requiring "Cool Dry Place" storage may need specialized logistics, adding to the total landed cost.

Payment terms are another financial consideration. The standard payment structure observed is 50% TT (Telegraphic Transfer) in advance and 50% TT against the copy of the Bill of Lading. This term balances the risk between buyer and supplier but requires careful cash flow management. Buyers should also consider the potential for currency fluctuations and the impact of international trade tariffs on the final price.

Typical Applications and Market Segmentation

Fosfomycin calcium serves diverse applications across multiple industries, driven by its chemical properties and regulatory approvals. The primary application is in the pharmaceutical sector, where it is used as an active pharmaceutical ingredient (API) for its antineoplastic and antibiotic properties. The product is suitable for oral dose administration, making it a versatile option for various treatment regimens. The specific application is often tied to the grade of the product; for instance, "Medicine Grade" and "Pharma Grade" materials are strictly reserved for human and veterinary pharmaceuticals.

Beyond human medicine, the product finds significant use in the animal feed industry. The data indicates applicability for poultry, livestock, and aquatic animals. This suggests that fosfomycin calcium is utilized as a feed additive to promote growth or prevent disease in agricultural settings. The "Food Grade" classification supports this application, ensuring the material meets safety standards for animal consumption. The distinction between human and animal applications is critical, as the regulatory requirements for each sector differ significantly.

The product is also noted for its suitability for specific demographic groups, including adults, children, and the elderly. This broad applicability highlights the versatility of the formulation and the need for precise dosing and purity control. The "Antineoplastic" function points to potential use in cancer treatment protocols, although this requires strict adherence to medical guidelines and regulatory approvals.

Supplier Evaluation and Quality Control Protocols

Selecting a reliable supplier for fosfomycin calcium requires a multi-faceted evaluation process that goes beyond price and basic certifications. Buyers should prioritize suppliers who demonstrate transparency in their manufacturing processes and quality control measures. The availability of test results, such as HPLC (High-Performance Liquid Chromatography) analysis, is a strong indicator of a supplier's commitment to quality. HPLC testing is essential for verifying purity and identifying impurities, ensuring the product meets the specified assay and purity thresholds.

The customization capabilities of the supplier are another key evaluation criterion. While some products are listed as "Non-Customized," others offer "Customized" options, allowing buyers to tailor specifications such as particle size, packaging, or purity levels. This flexibility is particularly valuable for large-scale manufacturers with specific formulation requirements. However, customization should not come at the expense of quality; buyers must ensure that any custom specifications are backed by rigorous testing and validation.

Storage conditions are a critical aspect of quality control. The product requires storage in a "Cool Dry Place" to maintain its stability and shelf life, which is typically cited as 2 to 3 years. Buyers must verify that their logistics partners can provide appropriate storage conditions during transit and warehousing. Failure to maintain these conditions can lead to degradation of the product, rendering it unsuitable for its intended use.

Supplier reliability is also assessed through their ability to meet lead times and handle large volumes. While specific lead times are not universally provided, the MOQ range suggests that suppliers are capable of handling both small and large orders. Buyers should request references or case studies from other clients in their industry to gauge the supplier's track record. Additionally, the presence of a robust quality management system, evidenced by ISO certification, is a prerequisite for long-term partnerships.

Long-Term Procurement and Supply Chain Resilience

Establishing a sustainable procurement strategy for fosfomycin calcium involves looking beyond immediate transactional needs to long-term supply chain resilience. The volatility of the global pharmaceutical market, driven by regulatory changes and geopolitical factors, necessitates a diversified supplier base. Relying on a single source can expose buyers to significant risks, including supply disruptions and price spikes. Therefore, maintaining relationships with multiple suppliers, each with different capabilities and geographic locations, is a prudent strategy.

The shelf life of the product, typically 2 to 3 years, offers a window for strategic inventory management. However, buyers must balance the benefits of bulk purchasing with the risks of inventory obsolescence. Overstocking can lead to financial losses if the product degrades or if market demand shifts. Conversely, understocking can result in production delays and lost revenue. A just-in-time (JIT) approach, supported by reliable suppliers with short lead times, can optimize inventory levels while ensuring continuous supply.

Regulatory compliance is a dynamic aspect of long-term procurement. As global standards evolve, suppliers must adapt their processes and certifications to remain compliant. Buyers should regularly audit their suppliers to ensure they continue to meet the latest regulatory requirements. This proactive approach helps mitigate the risk of non-compliance and ensures that the supply chain remains robust against regulatory changes.

Finally, the potential for customization and innovation should be leveraged to drive long-term value. Suppliers who invest in R&D and offer advanced formulations can provide a competitive advantage to their buyers. By collaborating with suppliers on product development, buyers can access higher-quality materials and more efficient production processes, ultimately enhancing the value proposition of their end products.